3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole has been researched along with kyotorphin in 1 studies
| Studies (3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole) | Trials (3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole) | Recent Studies (post-2010) (3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole) | Studies (kyotorphin) | Trials (kyotorphin) | Recent Studies (post-2010) (kyotorphin) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 168 | 0 | 22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, T; Motoyama, Y; Ochi, T | 1 |
1 other study(ies) available for 3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole and kyotorphin
| Article | Year |
|---|---|
The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Dipeptides; Endorphins; Enzyme Inhibitors; Guanylate Cyclase; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Methylene Blue; Mice; Morphine; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pain Measurement; Pyrazoles; Receptors, Opioid; Spinal Cord; Sulfoxides | 2000 |